Trial site
Kapiolani Medical Center for Women and Children
- 174running trials
- 63closed trials
The trials here
What the 243 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers110 trials
- Lung cancer31 trials
- Sarcoma29 trials
- Acute lymphoblastic leukaemia26 trials
- Ovarian cancer23 trials
- Neuroblastoma22 trials
- Kidney cancer18 trials
- Colorectal cancer15 trials
- Melanoma12 trials
- Metastatic breast cancer11 trials
- Endometrial cancer10 trials
- Prostate cancer9 trials
- and 35 more
- Phase
- Phase 3105 trials
- Phase 279 trials
- Phase 2/317 trials
- Phase 1/29 trials
- Status
- Active, not recruiting122 trials
- Completed60 trials
- Recruiting50 trials
- Suspended6 trials
- Terminated3 trials
- Not yet recruiting2 trials
- Lead sponsor
- National Cancer Institute (NCI)106 trials
- Children's Oncology Group57 trials
- SWOG Cancer Research Network23 trials
- ECOG-ACRIN Cancer Research Group12 trials
- Alliance for Clinical Trials in Oncology10 trials
- and 16 more
Running trials
Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Recruiting
Recruiting
Recruiting
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Recruiting
Active, not recruiting
Recruiting
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Recruiting
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Recruiting
Recruiting
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Recruiting
Active, not recruiting
Active, not recruiting
A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor
Recruiting
Active, not recruiting
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Active, not recruiting
Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
Active, not recruiting
Recruiting
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Showing 50 of 174.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers31 recruiting
- Acute lymphoblastic leukaemia9 recruiting
- Acute myeloid leukaemia6 recruiting
- Neuroblastoma6 recruiting
- Ovarian cancer6 recruiting
- Lung cancer5 recruiting
- Sarcoma5 recruiting
- Colorectal cancer3 recruiting
- Down syndrome3 recruiting
- Myelodysplastic syndromes3 recruiting
- Myeloproliferative neoplasms3 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Chronic myeloid leukaemia2 recruiting
- Endometrial cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Kidney cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Pancreatic cancer2 recruiting
- Prostate cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Aplastic anaemia1 recruiting
- Cytomegalovirus infection1 recruiting
- Hearing loss1 recruiting
- Heart failure1 recruiting
- Hodgkin lymphoma1 recruiting
- Melanoma1 recruiting
- Multiple myeloma1 recruiting
- Neuroendocrine tumours1 recruiting
- Neurofibromatosis type 11 recruiting
Closed trials
Terminated
Completed
Completed
Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian
Terminated
Completed
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer
Completed
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
Completed
Completed
Terminated
Completed
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
Completed
Completed
Completed
Completed
Completed
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Completed
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Completed
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Completed
Completed
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Completed
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Completed
Completed
A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
Completed
Completed
Completed
Completed
Completed
Completed
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer
Completed
Completed
Completed
Completed
Completed
S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Completed
Completed
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Completed
Completed
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Completed
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
Completed
Completed
Completed
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
Completed
Showing 50 of 63.
Site data: ClinicalTrials.govUpdated 19 Nov 2026